SLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
SLT is a technical trading company offering testing and safety control devices for the medical technology and healthcare sectors. The company specializes in products for safety and performance verification of medical equipment and bioimaging, complemented by calibration services and training programs. Its customers include OEMs which produce medical equipment, global service providers and hospitals. Founded in 1949, SLT employs 19 people and is based in Milan, Italy.
Indutrade is an international technology and industrial business group comprising more than 200 companies across 30 countries, primarily in Europe. The group operates through five business areas: industrial and engineering; infrastructure and construction; life science; process, energy and water; and technology and systems solutions. Listed on Nasdaq Stockholm, Indutrade’s majority shareholder is the Lundberg family through its holding company Lundbergföretagen, which holds a 26.6 percent stake.
Oaklins’ team in Italy acted as the exclusive financial advisor to the shareholders of SLT.
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more